Abstract
In order to test assumptions about possible complications during the clinical use of cilostazol drugs, we conducted a clinical study of the frequency of complications of antiplatelet cilostazol and its analogues in patients with diabetic foot syndrome at the Diabetic Foot Center of the Kazan Medical University Clinic. The study compared 2 analogues of cilostazol. The patients were divided into 2 groups representative of the initial data, in accordance with the analogue obtained. In these groups, the frequency of side effects, the frequency of favorable and unfavorable outcomes was compared.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
